Rockefeller Capital Management
COCP icon

Rockefeller Capital Management’s Cocrystal Pharma COCP Stock Holding History

Rockefeller Capital Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-167
Closed -$3K – 2605
2020
Q2 		$3K Hold
167
– – ﹤0.01% 2212
2020
Q1 		$1K Hold
167
– – ﹤0.01% 2257
2019
Q4 		$1K Hold
167
– – ﹤0.01% 1965
2019
Q3 		$4K Buy
+167
New +$4.33K ﹤0.01% 1672

Other funds holding COCP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Rockefeller Capital Management's COCP Position: Q3 2020 in Review

Rockefeller Capital Management sold out of Cocrystal Pharma (COCP) in Q3 2020, closing a stake of 167 shares — an estimated $3K sold.

Rockefeller Capital Management first reported a position in COCP in Q3 2019 and held it in 4 quarters. The position peaked at $4K in Q3 2019. 25 funds tracked by Wall St. Rank hold COCP as of Q3 2020.

  • Rockefeller Capital Management reported no remaining Cocrystal Pharma position as of Q3 2020 after selling out during the quarter.
  • Rockefeller Capital Management sold 167 Cocrystal Pharma shares in Q3 2020, an estimated $3K.
  • Rockefeller Capital Management first reported a position in Cocrystal Pharma in Q3 2019 and held it in 4 quarters.
  • Rockefeller Capital Management's Cocrystal Pharma position peaked at $4K in Q3 2019.
  • 25 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2020.

Based on Rockefeller Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.